Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bonneterre

Showing results (71-80 of 194) with videos related to

Pageof 20
Sort By:
Bulletin Du Cancer|September 30, 1998
The development of a French version of a questionnaire on the quality of life in cancerology (Functional Living Index-Cancer: FLIC)M Mercier, J Bonneterre, S Schraub, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1993
Unexpected fatal toxicity related to low-dose leucovorin with 5-fluorouracil treatment in metastatic colorectal cancerA Adenis, J Bonneterre, J M Pion, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|April 1, 1995
Presence of the two growth hormone receptor messenger RNA isoforms in human breast cancerC Decouvelaere, J P Peyrat, J Bonneterre, et al.
Cancer Research|November 15, 1988
Insulin-like growth factor 1 receptors in human breast cancer and their relation to estradiol and progesterone receptorsJ P Peyrat, J Bonneterre, R Beuscart, et al.
Anticancer Research|July 1, 1996
Ineffectiveness of sequential high dose methotrexate and 5-fluorouracil combined with epirubicin (FEMTX regimen) as a salvage therapy in advanced colorectal cancers and other gastrointestinal tumorsA Adenis, N Leriche, J M Pion, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 27, 2007
ErbB/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features and prognosisF Révillion, V Lhotellier, L Hornez, et al.
Annales D'Endocrinologie|January 1, 1984
[EGF receptors in human breast cancer. Relation to hormonal receptors]J P Peyrat, J Bonneterre, B Vandewalle, et al.
Cancer Research|September 1, 1987
Prognostic significance of prolactin receptors in human breast cancerJ Bonneterre, J P Peyrat, R Beuscart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 17, 2005
Cost-effectiveness analysis of breast cancer adjuvant treatment: FEC 50 versus FEC 100 (FASG05 study)J Bonneterre, C Bercez, M-E Bonneterre, et al.
Bulletin Du Cancer|July 21, 2000
[Improvement in the control of chemotherapy induced emesis with ondansetron, methylprednisolone and lorazepam combination in patients treated by a moderate emetic treatment and uncontrolled by a previous antiemetic combination]J L Harousseau, R Zittoun, J Bonneterre, et al.
Pageof 20

Showing results (71-80 of 194) with videos related to

Sort By:
Pageof 20
Bulletin Du Cancer|September 30, 1998
The development of a French version of a questionnaire on the quality of life in cancerology (Functional Living Index-Cancer: FLIC)M Mercier, J Bonneterre, S Schraub, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1993
Unexpected fatal toxicity related to low-dose leucovorin with 5-fluorouracil treatment in metastatic colorectal cancerA Adenis, J Bonneterre, J M Pion, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|April 1, 1995
Presence of the two growth hormone receptor messenger RNA isoforms in human breast cancerC Decouvelaere, J P Peyrat, J Bonneterre, et al.
Cancer Research|November 15, 1988
Insulin-like growth factor 1 receptors in human breast cancer and their relation to estradiol and progesterone receptorsJ P Peyrat, J Bonneterre, R Beuscart, et al.
Anticancer Research|July 1, 1996
Ineffectiveness of sequential high dose methotrexate and 5-fluorouracil combined with epirubicin (FEMTX regimen) as a salvage therapy in advanced colorectal cancers and other gastrointestinal tumorsA Adenis, N Leriche, J M Pion, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 27, 2007
ErbB/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features and prognosisF Révillion, V Lhotellier, L Hornez, et al.
Annales D'Endocrinologie|January 1, 1984
[EGF receptors in human breast cancer. Relation to hormonal receptors]J P Peyrat, J Bonneterre, B Vandewalle, et al.
Cancer Research|September 1, 1987
Prognostic significance of prolactin receptors in human breast cancerJ Bonneterre, J P Peyrat, R Beuscart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 17, 2005
Cost-effectiveness analysis of breast cancer adjuvant treatment: FEC 50 versus FEC 100 (FASG05 study)J Bonneterre, C Bercez, M-E Bonneterre, et al.
Bulletin Du Cancer|July 21, 2000
[Improvement in the control of chemotherapy induced emesis with ondansetron, methylprednisolone and lorazepam combination in patients treated by a moderate emetic treatment and uncontrolled by a previous antiemetic combination]J L Harousseau, R Zittoun, J Bonneterre, et al.
Pageof 20